Feasibility of a 10-week self-guided digital program for functional hypothalamic amenorrhea
Official title: Feasibility and Acceptability of a Digital Psychoeducational Self-help Program for Women With Functional Hypothalamic Amenorrhea: a Single-arm Pilot Study (HEAL-FHA Pilot)
Run by Karolinska Institutet · NCT07589868 · Data updated 2026-11-12
This pilot test checks whether a 10-week, self-guided web program for FHA is doable and acceptable for women, to pave the way for a larger trial.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 15 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 2 sites (Stockholm, Stockholm County and 1 other locations) |
| Status | Recruiting |
| Started | November 2, 2026 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07589868 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18-40 with gynecologist-verified FHA (hypogonadotropic hypogonadism), fluent in Swedish, with internet access and BankID.
✕Probably not a fit
Women with other causes of amenorrhea (pregnancy, thyroid disease, hyperprolactinemia, PCOS), or those with severe psychiatric conditions or eating disorders requiring more intensive care, may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-arm feasibility study of a 10-week, web-based psychoeducational program designed for women with functional hypothalamic amenorrhea. The intervention is delivered remotely through a secure platform with weekly modules that cover energy balance, stress, nutrition, physical activity, and wellbeing, without therapist support. Participants are recruited from gynecology clinics and confirmed to have FHA using clinical evaluation and hormonal assessment, then complete assessments at baseline, after 10 weeks, and 4 and 8 weeks post-intervention. The study aims to determine feasibility and acceptability, rather than clinical efficacy, in preparation for a future randomized trial. Data include clinical, hormonal, and DIAMOND psychiatric interviews, plus self-report measures to track changes over time.
Why it matters
Potential benefit: If successful, the program could offer a scalable, accessible option to help manage FHA by improving energy balance and well‑being.
How similar studies have gone: Prior digital or self-guided interventions for FHA or related hormone-function issues have shown feasibility in pilot formats, but this specific 10-week self-guided platform is novel in its fully remote, therapist-free design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Women aged 18-40 years with functional hypothalamic amenorrhea (hypogonadotropic hypogonadism) verified by a gynecologist; able to read and understand Swedish; access to an internet-enabled device and BankID; written informed consent. Exclusion Criteria: Current anorexia nervosa, bulimia nervosa or binge-eating disorder according to the DIAMOND structured diagnostic interview (other specified feeding or eating disorder is not an exclusion criterion); severe psychiatric comorbidity requiring other or more intensive care, including psychosis; insufficient Swedish proficiency; other causes of amenorrhea, including pregnancy, thyroid disease, hyperprolactinemia and polycystic ovary syndrome.
Where it's running
-
Women's Health Clinic, Karolinska University Hospital
Stockholm, Stockholm County, Sweden Recruiting -
Karolinska University Hospital
Stockholm, Sweden Recruiting
Study contacts
- Study coordinator: Hedvig Engberg, MD, Associate Professor
- Email: hedvig.engberg@ki.se
- Phone: +46 08 123 700 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combining Chinese and Western medicine to restore menstrual cycles in hypothalamic amenorrhea
This program will try a two-step approach—Western medicine to quickly restore menstrual bleeding and traditional Chinese medicine to support long-term hormonal balance—for women with functional hypothalamic amenorrhea.
-
Mibavademab for adult women with functional hypothalamic amenorrhea
This trial tests whether the experimental drug mibavademab helps adult women with functional hypothalamic amenorrhea make the hormones needed to resume ovulation and menstrual cycles.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
Sensory nerve tests after finger nerve injury
This study tests whether neurophysiological measurements can reflect finger sensation changes after digital nerve injury, using patients as their own controls.
-
National Highly Specialized Care for Severe Self-Harm and Eating Disorders in Swedish Youth
This observational study tests how well NHV, a highly specialized care program, works for children and teens with severe self-harm or eating disorders by asking patients and their parents about their experiences and what changes they notice.
-
Specialist Supportive Clinical Management for teens with anorexia or atypical anorexia
This study tests a teen-focused SSCM approach to help 13-17 year-olds with anorexia nervosa or atypical anorexia nervosa when other treatments haven’t worked or can’t be used.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.